Dr. Martens (LON:DOCS) Hits New 52-Week Low – Time to Sell?
by Teresa Graham · The Cerbat GemShares of Dr. Martens plc (LON:DOCS – Get Free Report) hit a new 52-week low during trading on Thursday . The company traded as low as GBX 47.52 ($0.62) and last traded at GBX 49.56 ($0.64), with a volume of 3938522 shares traded. The stock had previously closed at GBX 53 ($0.69).
Dr. Martens Price Performance
The company has a current ratio of 2.85, a quick ratio of 1.13 and a debt-to-equity ratio of 127.27. The stock has a market capitalization of £481.11 million, a P/E ratio of 7.03, a PEG ratio of 6.40 and a beta of 0.11. The company has a fifty day simple moving average of GBX 63.45 and a two-hundred day simple moving average of GBX 63.17.
Dr. Martens Cuts Dividend
The firm also recently declared a dividend, which will be paid on Tuesday, April 8th. Investors of record on Thursday, March 6th will be paid a dividend of GBX 0.85 ($0.01) per share. This represents a dividend yield of 1.47%. The ex-dividend date is Thursday, March 6th. Dr. Martens’s dividend payout ratio (DPR) is 42.53%.
Insider Activity at Dr. Martens
In related news, insider Giles Wilson acquired 32,640 shares of the company’s stock in a transaction that occurred on Tuesday, March 25th. The stock was acquired at an average price of GBX 54 ($0.70) per share, for a total transaction of £17,625.60 ($22,887.42). Insiders have acquired 33,338 shares of company stock worth $1,807,831 over the last ninety days. Company insiders own 4.36% of the company’s stock.
Dr. Martens Company Profile
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Read More
- Five stocks we like better than Dr. Martens
- What is the S&P 500 and How It is Distinct from Other Indexes
- Shares of RH Down Nearly 40%: Where Investors Can Turn To Now
- The Significance of Brokerage Rankings in Stock Selection
- Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian
- 3 Small Caps With Big Return Potential
- Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?